Innovation
9 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 255 times.
| Year | Filings |
|---|---|
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Investor mix
5 investors on record; lead investors include Genextra, Sofinnova Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 1 | 20% |
| Other / undisclosed | 1 | 20% |